Bacillus-produced surfactin induces Tregs to inhibit chronic inflammation and attenuate atherosclerosis in mice.
Tregs secrete IL-10 and TGF-β to create an anti-inflammatory milieu in the aorta wall for athero-protection.
Surfactin has potential as a novel immunomodulator against atherosclerosis.